140 related articles for article (PubMed ID: 22011934)
1. Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes.
Zhou Y; Wang W; Zheng D; Peng S; Xiong W; Ma J; Zeng Z; Wu M; Zhou M; Xiang J; Xiang B; Li X; Li X; Li G
Med Oncol; 2012 Sep; 29(3):1456-62. PubMed ID: 22011934
[TBL] [Abstract][Full Text] [Related]
2. Expression levels of JNK associated with polymorphic lactotransferrin haplotypes in human nasopharyngeal carcinoma.
Luo G; Zhou Y; Yi W; Yi H
Oncol Lett; 2016 Aug; 12(2):1085-1094. PubMed ID: 27446399
[TBL] [Abstract][Full Text] [Related]
3. The relationship of haplotype in lactotransferrin and its expression levels in Chinese Han ovarian cancer.
Cao L; Zhou Y; Li X; Yi H
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):884-90. PubMed ID: 21937479
[TBL] [Abstract][Full Text] [Related]
4. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
Deng M; Ye Q; Qin Z; Zheng Y; He W; Tang H; Zhou Y; Xiong W; Zhou M; Li X; Yan Q; Ma J; Li G
Tumour Biol; 2013 Jun; 34(3):1793-800. PubMed ID: 23479198
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.
Yi HM; Li H; Peng D; Zhang HJ; Wang L; Zhao M; Yao KT; Ren CP
Oncol Res; 2006; 16(6):261-72. PubMed ID: 17476971
[TBL] [Abstract][Full Text] [Related]
6. Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma.
Zhang W; Fan S; Zou G; Shi L; Zeng Z; Ma J; Zhou Y; Li X; Zhang X; Li X; Tan M; Xiong W; Li G
Tumour Biol; 2015 Feb; 36(2):675-83. PubMed ID: 25286756
[TBL] [Abstract][Full Text] [Related]
7. Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.
Deng M; Zhang W; Tang H; Ye Q; Liao Q; Zhou Y; Wu M; Xiong W; Zheng Y; Guo X; Qin Z; He W; Zhou M; Xiang J; Li X; Ma J; Li G
Oncogene; 2013 Sep; 32(36):4273-83. PubMed ID: 23069661
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT
Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627
[TBL] [Abstract][Full Text] [Related]
9. Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines.
Zhang H; Feng X; Liu W; Jiang X; Shan W; Huang C; Yi H; Zhu B; Zhou W; Wang L; Liu C; Zhang L; Jia W; Huang W; Li G; Shi J; Wanggou S; Yao K; Ren C
J Cell Biochem; 2011 Jul; 112(7):1832-43. PubMed ID: 21400573
[TBL] [Abstract][Full Text] [Related]
10. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway.
Zhou Y; Zeng Z; Zhang W; Xiong W; Wu M; Tan Y; Yi W; Xiao L; Li X; Huang C; Cao L; Tang K; Li X; Shen S; Li G
Int J Cancer; 2008 Nov; 123(9):2065-72. PubMed ID: 18697201
[TBL] [Abstract][Full Text] [Related]
11. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
13. The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of nasopharyngeal carcinoma in a Chinese population.
Qin X; Peng Q; Lao X; Chen Z; Lu Y; Lao X; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
Tumour Biol; 2014 Mar; 35(3):1917-24. PubMed ID: 24101193
[TBL] [Abstract][Full Text] [Related]
14. Study of single nucleotide polymorphisms of tumour necrosis factors and HSP genes in nasopharyngeal carcinoma in North East India.
Lakhanpal M; Singh LC; Rahman T; Sharma J; Singh MM; Kataki AC; Verma S; Pandrangi SL; Singh YM; Wajid S; Kapur S; Saxena S
Tumour Biol; 2016 Jan; 37(1):271-81. PubMed ID: 26198046
[TBL] [Abstract][Full Text] [Related]
15. Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.
Ban EZ; Lye MS; Chong PP; Yap YY; Lim SYC; Abdul Rahman H
PLoS One; 2017; 12(11):e0187200. PubMed ID: 29121049
[TBL] [Abstract][Full Text] [Related]
16. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
[TBL] [Abstract][Full Text] [Related]
17. Single Nucleotide Polymorphism and mRNA Expression of
Gołąbek K; Rączka G; Gaździcka J; Miśkiewicz-Orczyk K; Zięba N; Krakowczyk Ł; Hudy D; Asman M; Misiołek M; Strzelczyk JK
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360322
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in interleukin 13 gene with the susceptibility to nasopharyngeal carcinoma in a Chinese population.
Wang R; Qin HM; Liao BY; Yang FL; Wang JL
Cytokine; 2019 Mar; 115():121-126. PubMed ID: 30472105
[TBL] [Abstract][Full Text] [Related]
19. [Expression, genetic and epigenetic alterations of LTF gene in nasopharyngeal carcinoma cell lines].
Yi HM; Li YC; Zhong RH
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):729-33. PubMed ID: 21163060
[TBL] [Abstract][Full Text] [Related]
20. Argonaute 2 and nasopharyngeal carcinoma: a genetic association study and functional analysis.
Li P; Meng J; Zhai Y; Zhang H; Yu L; Wang Z; Zhang X; Cao P; Chen X; Han Y; Zhang Y; Chen H; Ling Y; Li Y; Cui Y; Bei JX; Zeng YX; He F; Zhou G
BMC Cancer; 2015 Nov; 15():862. PubMed ID: 26545861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
